Sunday, June 21, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 502 of 1,261

  1. US 10273292

    Non-HIV vaccine antigen from the vaginal microbiota capable of inducing a mucosal neutralizing protective antibody response against HIV infection

    B Cell Design SAS · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  2. US 10273291

    Focused evolution of HIV-1 neutralizing antibodies revealed by crystal structures and deep sequencing

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  3. US 10273288

    Neutralizing antibodies to Ebola virus glycoprotein and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  4. US 10273245

    1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases

    Takeda Pharmaceutical Company Limited · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  5. US 10273233

    Inhibitors of influenza viruses replication

    Vertex Pharmaceuticals Incorporated · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  6. US 10273244

    Substituted hexahydropyrrolo[3,4-b]pyrroles and hexahydrocyclopenta[c]pyrroles as dopamine receptor modulators

    Indivior UK Limited · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  7. US 10273225

    Pyrazines as modulators of GPR6

    Takeda Pharmaceutical Company Limited · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  8. US 10273189

    Zirconia composition, zirconia pre-sintered body and zirconia sintered body, and dental product

    KURARAY NORITAKE DENTAL INC. · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  9. US 10273228

    Hepatitis B viral assembly effectors

    ASSEMBLY BIOSCIENCES, INC. · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  10. US 10272607

    Manufacturing of small film strips

    Aquestive Therapeutics, Inc. · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  11. US 10272163

    Factor VIII mutation repair and tolerance induction

    THE UNITED STATES OF AMERICA REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  12. US 10272184

    Hydrogel membrane for adhesion prevention

    The Board of Regents of the University of Texas System · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  13. US 10272173

    Radioactive bone cement

    The Regents of the University of California · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  14. US 10272158

    Compounds for treating biofilm infection

    The Board of Regents of the University of Texas System · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  15. US 10273307

    Humanized anti-CD134 (OX40) antibodies and uses thereof

    Biocerox Products B.V. · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  16. US 10272132

    Peptide and peptidomimetic inhibitors

    RA PHARMACEUTICALS, INC. · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  17. US 10272137

    Compositions and methods relating to myomaker-induced muscle cell fusion

    The Board of Regents of the University of Texas System · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  18. US 10272093

    Use of H3K9me3 modulation for enhancing cognitive function

    The Regents of the University of California · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  19. US 10272084

    Histone deacetylase 6 selective inhibitors for the treatment of cisplatin-induced peripheral neuropathy

    The Board of Regents of the University of Texas System · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  20. US 10272075

    Method and composition for treating an alpha adrenoceptor-mediated condition

    VANDA PHARMACEUTICALS INC. · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  21. US 10272076

    Methods for the administration of iloperidone

    VANDA PHARMACEUTICALS INC. · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  22. US 10272055

    Therapeutic compounds and methods

    The Regents of the University of California · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  23. US 10272051

    Method to treat atopic dermatitis

    AXIM BIOTECHNOLOGIES. INC. · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  24. US 10272037

    Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract

    The Regents of the University of California · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.